Therapeutic outcome of quercetin nanoparticles on Cerastes cerastes venom-induced hepatorenal toxicity: a preclinical study

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Gutierrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. Snakebite envenoming. Nat. Rev. Dis. Primers 3, 17063 (2017).
  MedlineGoogle Scholar
• 2. Harrison RA, Hargreaves A, Wagstaff SC, Faragher B, Lalloo DG. Snake envenoming: a disease of poverty. PLOS Negl. Trop. Dis. 3(12), e569 (2009).
  MedlineGoogle Scholar
• 3. Chippaux JP. Snakebite envenomation turns again into a neglected tropical disease! J. Venom. Anim. Toxins Incl. Trop. Dis. 23, 38 (2017).
  MedlineGoogle Scholar
• 4. World Health Organization. Snakebite envenoming: a strategy for prevention and control. WHO Document Production Services, 1–50, Geneva, Switzerland (2019). https://apps.who.int/iris/handle/10665/312195 (Accessed 2 June 2020). • Describes the global strategy of the WHO to reduce the impact of snakebite envenoming.
  Google Scholar
• 5. Williams DJ, Faiz MA, Abela-Ridder B et al. Strategy for a globally coordinated response to a priority neglected tropical disease: snakebite envenoming. PLOS Negl. Trop. Dis. 13(2), e0007059 (2019).
  MedlineGoogle Scholar
• 6. Laraba-Djebari F, Martin-Eauclaire M-F, Marchot P. A fibrinogen-clotting serine proteinase from Cerastes cerastes (horned viper) venom with arginine-esterase and amidase activities. Purification, characterization and kinetic parameter determination. Toxicon 30(11), 1399–1410 (1992).
  Medline CASGoogle Scholar
• 7. Laraba-Djébari F, Martin-Eauclaire M, Mauco G, Marchot P. Afaâcytin, αβ-fibrinogenase from Cerastes cerastes (horned viper) venom, activates purified factor X and induces serotonin release from human blood platelets. Eur. J. Biochem. 233(3), 756–765 (1995).
  Medline CASGoogle Scholar
• 8. Chippaux JP. Venomous and poisonous animals. II. Viper bites. Med. Trop. (Mars.) 66(5), 423–428 (2006).
  Medline CASGoogle Scholar
• 9. Allane D, Oussedik-Oumehdi H, Harrat Z, Seve M, Laraba-Djebari F. Isolation and characterization of an anti-leishmanial disintegrin from Cerastes cerastes venom. J. Biochem. Mol. Toxicol. 32(2), e22018 (2018).
  Google Scholar
• 10. Ami A, Oussedik-Oumehdi H, Laraba-Djebari F. Biochemical and biological characterization of a dermonecrotic metalloproteinase isolated from Cerastes cerastes snake venom. J. Biochem. Mol. Toxicol. 31(2), 2 (2016).
  Google Scholar
• 11. Bennacef-Heffar N, Laraba-Djebari F. Beneficial effects of heparin and L arginine on dermonecrosis effect induced by Vipera lebetina venom: involvement of NO in skin regeneration. Acta Trop. 171, 226–232 (2017).
  Medline CASGoogle Scholar
• 12. Nourreddine FZ, Oussedik-Oumehdi H, Laraba-Djebari F. Myotoxicity induced by Cerastes cerastes venom: beneficial effect of heparin in skeletal muscle tissue regeneration. Acta Trop. 202, 105274 (2020).
  Medline CASGoogle Scholar
• 13. Oussedik-Oumehdi H, Laraba-Djebari F. Irradiated Cerastes cerastes venom as a novel tool for immunotherapy. Immunopharmacol. Immunotoxicol. 30(1), 37–52 (2008).
  Medline CASGoogle Scholar
• 14. Khelfi A, Oussedik-Oumehdi H, Laraba-Djebari F. Therapeutic outcome of anti-inflammatory and antioxidative medicines on the dermonecrotic activity of Cerastes cerastes venom. Inflammation 45(4), 1700–1719 (2022).
  Medline CASGoogle Scholar
• 15. Cherifi F, Laraba-Djebari F. Pathophysiological and pharmacological effects of snake venom components: molecular targets. Clin. Toxicol. 4(2), 1–9 (2014).
  Google Scholar
• 16. Sunitha K, Hemshekhar M, Thushara RM et al. Inflammation and oxidative stress in viper bite: an insight within and beyond. Toxicon 98, 89–97 (2015). •• Describes the contributory role of inflammation and oxidative stress in envenoming pathogenesis.
  Medline CASGoogle Scholar
• 17. Marcussi S, Santos PR, Menaldo DL et al. Evaluation of the genotoxicity of Crotalus durissus terrificus snake venom and its isolated toxins on human lymphocytes. Mut. Res. 724(1–2), 59–63 (2011).
  Medline CASGoogle Scholar
• 18. Kebir-Chelghoum H, Laraba-Djebari F. Cytotoxicity of Cerastes cerastes snake venom: involvement of imbalanced redox status. Acta Trop. 173, 116–124 (2017).
  Medline CASGoogle Scholar
• 19. Chippaux JP. Guidelines for the production, control and regulation of snake antivenom immunoglobulins. Biol. Aujourdhui 204(1), 87–91 (2010).
  MedlineGoogle Scholar
• 20. Gutiérrez JM, Burnouf T, Harrison RA et al. A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming. Bull. World Health Organ. 92(7), 526–532 (2014).
  MedlineGoogle Scholar
• 21. Lalloo DG, Theakston RDG. Snake antivenoms. J. Toxicol. Clin. Toxicol. 41(3), 277–290 (2003).
  Medline CASGoogle Scholar
• 22. Harrison RA, Oluoch GO, Ainsworth S et al. Preclinical antivenom – efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa. PLOS Negl. Trop. Dis. 11(10), e0005969 (2017).
  MedlineGoogle Scholar
• 23. De Silva HA, Ryan NM, De Silva HJ. Adverse reactions to snake antivenom, and their prevention and treatment. Br. J. Clin. Pharmacol. 81(3), 446–452 (2016).
  MedlineGoogle Scholar
• 24. Williams D, Gutiérrez JM, Harrison R et al. The Global Snake Bite Initiative: an antidote for snake bite. Lancet 375(9708), 89–91 (2010).
  MedlineGoogle Scholar
• 25. Williams HF, Layfield HJ, Vallance T et al. The urgent need to develop novel strategies for the diagnosis and treatment of snakebites. Toxins 11(6), 363 (2019).
  Medline CASGoogle Scholar
• 26. Sanhajariya S, Duffull SB, Isbister GK. Pharmacokinetics of snake venom. Toxins 10(2), 73 (2018).
  MedlineGoogle Scholar
• 27. Sharma RD, Katkar GD, Sundaram MS, Swethakumar B, Girish KS, Kemparaju K. Melatonin inhibits snake venom and antivenom induced oxidative stress and augments treatment efficacy. Acta Trop. 169, 14–25 (2017).
  Medline CASGoogle Scholar
• 28. Bulfone TC, Samuel SP, Bickler PE, Lewin MR. Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite. J. Trop. Med. 2018, 4320175 (2018).
  MedlineGoogle Scholar
• 29. Girish KS, Katkar GD, Harrison RA, Kemparaju K. Research into the causes of venom-induced mortality and morbidity identifies new therapeutic opportunities. Am. J. Trop. Med. Hyg. 100(5), 1043–1048 (2019).
  Medline CASGoogle Scholar
• 30. Gutiérrez JM, Albulescu L-O, Clare RH et al. The search for natural and synthetic inhibitors that would complement antivenoms as therapeutics for snakebite envenoming. Toxins 13(7), 451 (2021). •• Discusses the key aspect in the search for novel venom inhibitory compounds and summarizes some of the most promising developments in this field.
  Medline CASGoogle Scholar
• 31. Clare RH, Hall SR, Patel RN, Casewell NR. Small molecule drug discovery for neglected tropical snakebite. Trends Pharmacol. Sci. 42(5), 340–353 (2021).
  Medline CASGoogle Scholar
• 32. Santhosh MS, Sundaram MS, Sunitha K, Kemparaju K, Girish KS. Viper venom-induced oxidative stress and activation of inflammatory cytokines: a therapeutic approach for overlooked issues of snakebite management. Inflamm. Res. 62(7), 721–731 (2013).
  Medline CASGoogle Scholar
• 33. Sachetto ATA, Rosa JG, Santoro ML. Rutin (quercetin-3-rutinoside) modulates the hemostatic disturbances and redox imbalance induced by Bothrops jararaca snake venom in mice. PLOS Negl. Trop. Dis. 12(10), e0006774 (2018).
  Medline CASGoogle Scholar
• 34. Gómez-Betancur I, Gogineni V, Salazar-Ospina A, León F. Perspective on the therapeutics of anti-snake venom. Molecules (Basel) 24(18), 3276 (2019).
  Medline CASGoogle Scholar
• 35. Zheng YZ, Deng G, Liang Q, Chen DF, Guo R, Lai RC. Antioxidant activity of quercetin and its glucosides from propolis: a theoretical study. Sci. Rep. 7(1), 7543 (2017).
  MedlineGoogle Scholar
• 36. Wu L, Zhang Q, Mo W et al. Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-beta1/Smads and PI3K/Akt pathways. Sci. Rep. 7(1), 9289 (2017).
  MedlineGoogle Scholar
• 37. Srivastava S, Somasagara RR, Hegde M et al. Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci. Rep. 6, 24049 (2016).
  Medline CASGoogle Scholar
• 38. Piovezana Bossolani GD, Silva BT, Colombo Martins Perles JV et al. Rheumatoid arthritis induces enteric neurodegeneration and jejunal inflammation, and quercetin promotes neuroprotective and anti-inflammatory actions. Life Sci. 238, 116956 (2019).
  MedlineGoogle Scholar
• 39. Güran M, Şanlıtürk G, Kerküklü NR, Altundağ EM, Süha Yalçın A. Combined effects of quercetin and curcumin on anti-inflammatory and antimicrobial parameters in vitro. Eur. J. Pharmacol. 859, 172486 (2019).
  MedlineGoogle Scholar
• 40. Ding Y, Li C, Zhang Y et al. Quercetin as a Lyn kinase inhibitor inhibits IgE-mediated allergic conjunctivitis. Food Chem. Toxicol. 135, 110924 (2020).
  Medline CASGoogle Scholar
• 41. Hou DX, Kumamoto T. Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. Antioxid. Redox Signal. 13(5), 691–719 (2010).
  Medline CASGoogle Scholar
• 42. Ribeiro D, Freitas M, Tomé SM et al. Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine/chemokine production in human whole blood. Inflammation 38(2), 858–870 (2015).
  Medline CASGoogle Scholar
• 43. Lin S, Zhang G, Liao Y, Pan J, Gong D. Dietary flavonoids as xanthine oxidase inhibitors: structure–affinity and structure–activity relationships. J. Agric. Food Chem. 63(35), 7784–7794 (2015).
  Medline CASGoogle Scholar
• 44. Crascì L, Basile L, Panico A et al. Correlating in vitro target-oriented screening and docking: inhibition of matrix metalloproteinases activities by flavonoids. Planta Med. 83(11), 901–911 (2017).
  Medline CASGoogle Scholar
• 45. Jing Z, Wang Z, Li X et al. Protective effect of quercetin on posttraumatic cardiac injury. Sci. Rep. 6(1), 30812 (2016).
  Medline CASGoogle Scholar
• 46. Khan H, Ullah H, Aschner M, Cheang WS, Akkol E. Neuroprotective effects of quercetin in Alzheimer’s disease. Biomolecules 10(1), 59 (2019).
  MedlineGoogle Scholar
• 47. Vafadar A, Shabaninejad Z, Movahedpour A et al. Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell Biosci. 10(1), 32 (2020).
  MedlineGoogle Scholar
• 48. Eid HM, Haddad PS. The antidiabetic potential of quercetin: underlying mechanisms. Curr. Med. Chem. 24(4), 355–364 (2017).
  MedlineGoogle Scholar
• 49. Pei Y, Parks JS, Kang HW. Quercetin alleviates high-fat diet-induced inflammation in brown adipose tissue. J. Funct. Foods 85, 104614 (2021).
  CASGoogle Scholar
• 50. Rich GT, Buchweitz M, Winterbone MS, Kroon PA, Wilde PJ. Towards an understanding of the low bioavailability of quercetin: a study of its interaction with intestinal lipids. Nutrients 9(2), 111 (2017).
  MedlineGoogle Scholar
• 51. Silva T, Gomes J, Bulhões L et al. Therapeutic potential of quercetin based on nanotechnology: a review. Revista Virtual Química 11, 1405–1416 (2019).
  Google Scholar
• 52. Pinheiro RGR, Pinheiro M, Neves AR. Nanotechnology innovations to enhance the therapeutic efficacy of quercetin. Nanomaterials 11(10), 2658 (2021). • Demonstrates the potential biomedical and healthcare applications of quercetin nanoparticles.
  Medline CASGoogle Scholar
• 53. Begines B, Ortiz T, Pérez-Aranda M et al. Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials 10(7), 1403 (2020).
  Medline CASGoogle Scholar
• 54. Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3(3), 1377–1397 (2011).
  Medline CASGoogle Scholar
• 55. Hamzaoui A, Laraba-Djebari F. Development and evaluation of polymeric nanoparticles as a delivery system for snake envenoming prevention. Biologicals 70, 44–52 (2021).
  Medline CASGoogle Scholar
• 56. Zhou Y, Chen D, Xue G et al. Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA. RSC Adv. 10(57), 34517–34526 (2020).
  Medline CASGoogle Scholar
• 57. Sun D, Li N, Zhang W et al. Quercetin-loaded PLGA nanoparticles: a highly effective antibacterial agent in vitro and anti-infection application in vivo. J. Nanopart. Res. 18(1), 3 (2015).
  Google Scholar
• 58. Yadav N, Tripathi AK, Parveen A. PLGA–quercetin nano-formulation inhibits cancer progression via mitochondrial dependent caspase-3,7 and independent FOXO1 activation with concomitant PI3K/AKT suppression. Pharmaceutics 14(7), 1326 (2022).
  Medline CASGoogle Scholar
• 59. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55(1), R1–R4 (1989).
  CASGoogle Scholar
• 60. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster models. Gastroenterology 87(6), 1344–1350 (1984).
  Medline CASGoogle Scholar
• 61. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J. Immunol. Methods 38(1), 161–170 (1980).
  Medline CASGoogle Scholar
• 62. Lightfoot YL, Chen J, Mathews CE. Oxidative stress and beta cell dysfunction. Methods Mol. Biol. 900, 347–362 (2012).
  Medline CASGoogle Scholar
• 63. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95(2), 351–358 (1979).
  Medline CASGoogle Scholar
• 64. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47(3), 469–474 (1974).
  Medline CASGoogle Scholar
• 65. Kondo H, Kondo S, Ikezawa H, Murata R, Ohsaka A. Studies on the quantitative method for determination of hemorrhagic activity of Habu snake venom. Jpn. J. Med. Sci. Biol. 13(1–2), 43–51 (1960).
  Medline CASGoogle Scholar
• 66. Theakston RD, Reid HA. Development of simple standard assay procedures for the characterization of snake venom. Bull. World Health Organ. 61(6), 949–956 (1983).
  Medline CASGoogle Scholar
• 67. Zielinska A, Carreiro F, Oliveira AM et al. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules 25(16), 3731 (2020).
  Medline CASGoogle Scholar
• 68. Zhang B, Sai Lung P, Zhao S, Chu Z, Chrzanowski W, Li Q. Shape dependent cytotoxicity of PLGA–PEG nanoparticles on human cells. Sci. Rep. 7(1), 7315 (2017).
  MedlineGoogle Scholar
• 69. Hickey JW, Santos JL, Williford JM, Mao HQ. Control of polymeric nanoparticle size to improve therapeutic delivery. J. Control. Rel. 219, 536–547 (2015).
  Medline CASGoogle Scholar
• 70. Owens DE 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307(1), 93–102 (2006).
  Medline CASGoogle Scholar
• 71. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5(4), 505–515 (2008).
  Medline CASGoogle Scholar
• 72. Fang J, Islam W, Maeda H. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers. Adv. Drug Deliv. Rev. 157, 142–160 (2020).
  Medline CASGoogle Scholar
• 73. Islam R, Maeda H, Fang J. Factors affecting the dynamics and heterogeneity of the EPR effect: pathophysiological and pathoanatomic features, drug formulations and physicochemical factors. Expert Opin. Drug Deliv. 19(2), 199–212 (2021).
  MedlineGoogle Scholar
• 74. Doane TL, Chuang C-H, Hill RJ, Burda C. Nanoparticle ζ -potentials. Acc. Chem. Res. 45(3), 317–326 (2012).
  Medline CASGoogle Scholar
• 75. Zhu X, Zeng X, Zhang X et al. The effects of quercetin-loaded PLGA–TPGS nanoparticles on ultraviolet B-induced skin damages in vivo. Nanomedicine 12(3), 623–632 (2016).
  Medline CASGoogle Scholar
• 76. Halder A, Mukherjee P, Ghosh S, Mandal S, Chatterji U, Mukherjee A. Smart PLGA nanoparticles loaded with quercetin: cellular uptake and in-vitro anticancer study. Mater. Today Proc. 5(3), 9698–9705 (2018).
  CASGoogle Scholar
• 77. Lozano O, Lazaro-Alfaro A, Silva-Platas C et al. Nanoencapsulated quercetin improves cardioprotection during hypoxia–reoxygenation injury through preservation of mitochondrial function. Oxid. Med. Cell. Longev. 2019, 7683051 (2019).
  MedlineGoogle Scholar
• 78. Ghosh A, Sarkar S, Mandal AK, Das N. Neuroprotective role of nanoencapsulated quercetin in combating ischemia–reperfusion induced neuronal damage in young and aged rats. PLOS ONE 8(4), e57735 (2013).
  Medline CASGoogle Scholar
• 79. Ersoz M, Erdemir A, Derman S, Arasoglu T, Mansuroglu B. Quercetin-loaded nanoparticles enhance cytotoxicity and antioxidant activity on C6 glioma cells. Pharm. Dev. Technol. 25(6), 757–766 (2020).
  Medline CASGoogle Scholar
• 80. Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem. Rev. 116(4), 2602–2663 (2016).
  Medline CASGoogle Scholar
• 81. Boumaiza S, Oussedik-Oumehdi H, Laraba-Djebari F. Pathophysiological effects of Cerastes cerastes and Vipera lebetina venoms: immunoneutralization using anti-native and anti-(60)Co irradiated venoms. Biologicals 44(1), 1–11 (2016).
  Medline CASGoogle Scholar
• 82. Al-Quraishy S, Dkhil MA, Abdel Moneim AE. Hepatotoxicity and oxidative stress induced by Naja haje crude venom. J. Venom. Anim. Toxins Incl. Trop. Dis. 20(1), 42–42 (2014).
  MedlineGoogle Scholar
• 83. Asmari AKA, Khan HA, Banah FA, Al Buraidi AA, Manthiri RA. Serum biomarkers for acute hepatotoxicity of Echis pyramidum snake venom in rats. Int. J. Clin. Exp. Med. 8(1), 1376–1380 (2015).
  MedlineGoogle Scholar
• 84. Franca R. Acute hepatotoxicity of Crotalus durissus terrificus (South American rattlesnake) venom in rats. J. Venom. Anim. Toxins Incl. Trop. Dis 15(1), 61–78 (2009).
  CASGoogle Scholar
• 85. Alfred S, Bates D, White J et al. Acute kidney injury following Eastern Russell’s viper (Daboia siamensis) snakebite in Myanmar. Kidney Int. Rep. 4(9), 1337–1341 (2019).
  MedlineGoogle Scholar
• 86. Vikrant S, Jaryal A, Parashar A. Clinicopathological spectrum of snake bite-induced acute kidney injury from India. World J. Nephrol. 6(3), 150–161 (2017).
  MedlineGoogle Scholar
• 87. Chaisakul J, Alsolaiss J, Charoenpitakchai M et al. Evaluation of the geographical utility of Eastern Russell’s viper (Daboia siamensis) antivenom from Thailand and an assessment of its protective effects against venom-induced nephrotoxicity. PLOS Negl. Trop. Dis. 13(10), e0007338 (2019).
  MedlineGoogle Scholar
• 88. Frezzatti R, Silveira PF. Allopurinol reduces the lethality associated with acute renal failure induced by Crotalus durissus terrificus snake venom: comparison with probenecid. PLOS Negl. Trop. Dis. 5(9), e1312 (2011).
  Medline CASGoogle Scholar
• 89. Albuquerque P, Da Silva Junior GB, Meneses GC et al. Acute kidney injury induced by Bothrops venom: insights into the pathogenic mechanisms. Toxins 11(3), 148 (2019).
  Medline CASGoogle Scholar
• 90. Sharma RD, Katkar GD, Sundaram MS et al. Oxidative stress-induced methemoglobinemia is the silent killer during snakebite: a novel and strategic neutralization by melatonin. J. Pineal Res. 59(2), 240–254 (2015).
  Medline CASGoogle Scholar
• 91. Zuliani JP, Soares AM, Gutiérrez JM. Polymorphonuclear neutrophil leukocytes in snakebite envenoming. Toxicon 187, 188–197 (2020).
  Medline CASGoogle Scholar
• 92. Lehman HK, Segal BH. The role of neutrophils in host defense and disease. J. Allergy Clin. Immunol. 145(6), 1535–1544 (2020).
  Medline CASGoogle Scholar
• 93. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 10(1), 45–65 (2003).
  Medline CASGoogle Scholar
• 94. Stone SF, Isbister GK, Shahmy S et al. Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation. PLOS Negl. Trop. Dis. 7(7), e2326 (2013).
  Medline CASGoogle Scholar
• 95. Katkar G, Shanmuga Sundaram M, Hemshekhar M et al. Melatonin alleviates Echis carinatus venom-induced toxicities by modulating inflammatory mediators and oxidative stress. J. Pineal Res. 56(3), 295–312 (2014).
  Medline CASGoogle Scholar
• 96. Crocker P, Zad O, Milling T, Maxson T, King B, Whorton E. Human cytokine response to Texas crotaline envenomation before and after antivenom administration. Am. J. Emerg. Med. 28(8), 871–879 (2010).
  MedlineGoogle Scholar
• 97. Zuliani JP, Soares AM, Gutierrez JM. Polymorphonuclear neutrophil leukocytes in snakebite envenoming. Toxicon 187, 188–197 (2020).
  Medline CASGoogle Scholar
• 98. Salazar E, Salazar AM, Taylor P et al. Contribution of endothelial cell and macrophage activation in the alterations induced by the venom of Micrurus tener tener in C57BL/6 mice. Mol. Immunol. 116, 45–55 (2019).
  Medline CASGoogle Scholar
• 99. Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr. Biol. 24(10), 034 (2014).
  Google Scholar
• 100. Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct. Target. Ther. 2(1), 17023 (2017).
  MedlineGoogle Scholar
• 101. Chitkara D, Nikalaje SK, Mittal A, Chand M, Kumar N. Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model. Drug Deliv. Transl. Res. 2(2), 112–123 (2012).
  Medline CASGoogle Scholar
• 102. Leopoldini M, Russo N, Chiodo S, Toscano M. Iron chelation by the powerful antioxidant flavonoid quercetin. J. Agric. Food Chem. 54(17), 6343–6351 (2006).
  Medline CASGoogle Scholar
• 103. Ugur or Ozgen S, Kılınc O, Selamoglu Z. Antioxidant activity of quercetin: a mechanistic review. Turk. J. Agric. For. 4(12), 1134–1138 (2016).
  Google Scholar
• 104. Li Y, Yao J, Han C et al. Quercetin, inflammation and immunity. Nutrients 8(3), 167 (2016). • Describes the pharmacological properties of quercetin.
  MedlineGoogle Scholar
• 105. Xu D, Hu MJ, Wang YQ, Cui YL. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules 24(6), 1123 (2019).
  Medline CASGoogle Scholar
• 106. Sun L, Xu G, Dong Y, Li M, Yang L, Lu W. Quercetin protects against lipopolysaccharide-induced intestinal oxidative stress in broiler chickens through activation of Nrf2 pathway. Molecules 25(5), 1053 (2020).
  Medline CASGoogle Scholar
• 107. Min Z, Yangchun L, Yuquan W, Changying Z. Quercetin inhibition of myocardial fibrosis through regulating MAPK signaling pathway via ROS. Pak. J. Pharm. Sci. 32(3 Special), 1355–1359 (2019).
  MedlineGoogle Scholar
• 108. Kobori M, Takahashi Y, Sakurai M et al. Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice. Mol. Nutr. Food Res. 60(2), 300–312 (2016).
  Medline CASGoogle Scholar
• 109. Dong YS, Wang JL, Feng DY et al. Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int. J. Med. Sci. 11(3), 282–290 (2014).
  MedlineGoogle Scholar
• 110. Li J, Sun Z, Luo G et al. Quercetin attenuates trauma-induced heterotopic ossification by tuning immune cell infiltration and related inflammatory insult. Front. Immunol. 12, 649285 (2021).
  Medline CASGoogle Scholar
• 111. Li C, Zhang W-J, Frei B. Quercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme induction. Redox Biol. 9, 104–113 (2016).
  Medline CASGoogle Scholar
• 112. Tong F, Liu S, Yan B, Li X, Ruan S, Yang S. Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium. Int. J. Nanomed. 12, 7799–7813 (2017).
  Medline CASGoogle Scholar
• 113. Cotrim CA, De Oliveira SC, Diz Filho EB et al. Quercetin as an inhibitor of snake venom secretory phospholipase A2. Chem. Biol. Interact. 189(1–2), 9–16 (2011). •• Study demonstrating quercetin’s inhibitory potential against snake venom secretory phospholipase A2.
  Medline CASGoogle Scholar
• 114. Gopi K, Anbarasu K, Renu K, Jayanthi S, Vishwanath BS, Jayaraman G. Quercetin-3-O-rhamnoside from Euphorbia hirta protects against snake venom induced toxicity. Biochim. Biophys. Acta 1860(7), 1528–1540 (2016).
  Medline CASGoogle Scholar
• 115. De Oliveira Toyama D, Gaeta HH, De Pinho MV et al. An evaluation of 3-rhamnosylquercetin, a glycosylated form of quercetin, against the myotoxic and edematogenic effects of sPLA 2 from Crotalus durissus terrificus. BioMed Res. Int. 341270(10), 18 (2014).
  Google Scholar
• 116. Srinivasa V, Sundaram MS, Anusha S et al. Novel apigenin based small molecule that targets snake venom metalloproteases. PLOS ONE 9(9), e106364 (2014).
  MedlineGoogle Scholar
• 117. Preciado LM, Comer J, Nunez V, Rey-Suarez P, Pereanez JA. Inhibition of a snake venom metalloproteinase by the flavonoid myricetin. Molecules 23(10), 2662 (2018).
  MedlineGoogle Scholar
• 118. Pereañez JA, Patiño AC, Rey-Suarez P, Núñez V, Henao Castañeda IC, Rucavado A. Glycolic acid inhibits enzymatic, hemorrhagic and edema-inducing activities of BaP1, a P-I metalloproteinase from Bothrops asper snake venom: insights from docking and molecular modeling. Toxicon 71, 41–48 (2013).
  Medline CASGoogle Scholar
• 119. Heinz SA, Henson DA, Austin MD, Jin F, Nieman DC. Quercetin supplementation and upper respiratory tract infection: a randomized community clinical trial. Pharmacol. Res. 62(3), 237–242 (2010).
  Medline CASGoogle Scholar
• 120. Buonerba C, De Placido P, Bruzzese D et al. Isoquercetin as an adjunct therapy in patients with kidney cancer receiving first-line sunitinib (QUASAR): results of a phase I trial. Front. Pharmacol. 9, 189 (2018).
  MedlineGoogle Scholar
• 121. Zwicker JI, Schlechter BL, Stopa JD et al. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. JCI Insight 4(4), e125851 (2019).
  MedlineGoogle Scholar
• 122. Mazloom Z, Abdollahzadeh S, Dabbaghmanesh M, Rezaianzadeh A. The effect of quercetin supplementation on oxidative stress, glycemic control, lipid profile and insulin resistance in type 2 diabetes: a randomized clinical trial. J. Health Sci. Surveillance Syst. 2(1), 8–14 (2014).
  MedlineGoogle Scholar
• 123. Hussain SA, Ahmed ZA, Mahwi TO, Aziz TA. Quercetin dampens postprandial hyperglycemia in type 2 diabetic patients challenged with carbohydrates load. Int. J. Diabetes Res. 1(3), 32–35 (2012).
  Google Scholar
• 124. Zahedi M, Ghiasvand R, Feizi A, Asgari G, Darvish L. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. Int. J. Prev. Med. 4(7), 777 (2013).
  MedlineGoogle Scholar
• 125. Kooshyar MM, Mozafari PM, Amirchaghmaghi M et al. A randomized placebo-controlled double blind clinical trial of quercetin in the prevention and treatment of chemotherapy-induced oral mucositis. J. Clin. Diagn. Res. 11(3), ZC46–ZC50 (2017).
  Medline CASGoogle Scholar
• 126. Pasdar Y, Oubari F, Zarif MN, Abbasi M, Pourmahmoudi A, Hosseinikia M. Effects of quercetin supplementation on hematological parameters in non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Clin. Nutr. Res. 9(1), 11–19 (2020).
  MedlineGoogle Scholar